retatrutide clinical trials phase 2 Availability & Timeline Eli Lilly infiltrates anti-obesity market

Both work by mimicking the gut hormone GLP-1 to suppress appetite

In the desire to have a lean, lithe, and supple body, it is possible to get attracted to some dubious fat-burners, with no scientific facts and undesirable consequences

Other GLP-1 Pills in the Pipeline Although Wegovy is the first GLP-1 pill the FDA has approved for weight management, drug manufacturers are funding trials for additional oral GLP-1 medications

Because retatrutide is newer, long-term stall data is limited

Eli Lilly: The Battle for Anti-Obesity Drug Market Dominance Table of Contents The global obesity crisis has sparked a multibillion-dollar showdown in the pharmaceutical world, with Novo Nordisk and Eli Lilly locked in an intense battle for supremacy